Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B G Pollock

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
The American Journal of Psychiatry|August 18, 1999
Three-year outcomes of maintenance nortriptyline treatment in late-life depression: a study of two fixed plasma levelsC F Reynolds, J M Perel, E Frank, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 12, 2000
Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depressionB G Pollock, R E Ferrell, B H Mulsant, et al.
JAMA|January 19, 1999
Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 yearsC F Reynolds, E Frank, J M Perel, et al.
Brain Research|November 24, 1998
Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correctionC C Meltzer, G Smith, J C Price, et al.
Acta Psychiatrica Scandinavica|February 1, 1996
Antidepressants and drug-metabolizing enzymes--expert group reportU A Meyer, R Amrein, L P Balant, et al.
Molecular Psychiatry|October 30, 2013
The SORL1 gene and convergent neural risk for Alzheimer's disease across the human lifespanD Felsky, P Szeszko, L Yu, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|December 12, 2001
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodologyL S Schneider, P N Tariot, C G Lyketsos, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
The American Journal of Psychiatry|August 18, 1999
Three-year outcomes of maintenance nortriptyline treatment in late-life depression: a study of two fixed plasma levelsC F Reynolds, J M Perel, E Frank, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 12, 2000
Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depressionB G Pollock, R E Ferrell, B H Mulsant, et al.
JAMA|January 19, 1999
Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 yearsC F Reynolds, E Frank, J M Perel, et al.
Brain Research|November 24, 1998
Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correctionC C Meltzer, G Smith, J C Price, et al.
Acta Psychiatrica Scandinavica|February 1, 1996
Antidepressants and drug-metabolizing enzymes--expert group reportU A Meyer, R Amrein, L P Balant, et al.
Molecular Psychiatry|October 30, 2013
The SORL1 gene and convergent neural risk for Alzheimer's disease across the human lifespanD Felsky, P Szeszko, L Yu, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|December 12, 2001
National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodologyL S Schneider, P N Tariot, C G Lyketsos, et al.
Pageof 13